was a positive correlation between cTnT levels and LVMI. Background. Cardiac troponin T (cTnT ) is a highly sensitive marker for the detection of myocardial Conclusion. These findings suggest that circulating cTnT may reflect left ventricular hypertrophy and/or damage. However, patients maintained on chronic dialysis often have increased serum cTnT concentra-myocardial ischaemia in dialysis patients, and indicate that ET-1 and big ET-1 might be associated with these tions without evidence of acute myocardial injury. The reason for this is unclear. In chronic haemodialysis conditions. patients, elevated plasma concentrations of big Key words: renal failure; troponin; endothelin; cardiac endothelin-1 (big ET-1) and endothelin-1 ( ET-1) have markers; creatine kinase isoenzymes; left ventricular been reported which may be associated with ischaemic hypertrophy heart disease. The aim of the present study was to investigate possible associations between cTnT, big ET-1, ET-1, other cardiac markers and cardiac disease in dialysis patients.
Introduction

Methods. Thirty-six haemodialysis (HD) patients and 26 peritoneal dialysis (PD) patients without symptoms
Cardiac disease is the leading cause of morbidity and of acute myocardial ischaemia were investigated. In all mortality in patients with end-stage renal disease patients, serum concentrations of cTnT (2nd genera-( ESRD). Myocardial infarction accounts for 30-50% tion ELISA), cardiac troponin I ( TnI ) (Opus, of cardiac deaths [1, 2] . Ischaemic heart disease appears Behring), creatine kinase MB (CKMB) mass and creatto be only partially due to coronary atherosclerosis ine kinase (CK ) were determined, in HD patients since in a group of dialysis patients with symptomatic before and after dialysis. Additionally, in HD patients, ischaemic heart disease more than 40% were shown to plasma ET-1 and big ET-1 were measured. In 27 HD have patent coronary arteries [3] . In these patients, patients, left ventricular mass index (LVMI ) was deterventricular hypertrophy, interstitial myocardial fibrosis mined. Patients with ischaemic heart disease (IHD) and endothelial dysfunction, which all limit the coronwere compared with non-IHD patients.
ary flow reserve available to the myocardium during Results. Serum cTnT was elevated (Á0.10 mg/l ) in 20 stress and which are frequent findings in ESRD, may of 36 HD patients and in eight of 26 PD patients. cTnI play a pathophysiological role. was elevated (Á0.5 mg/l ) in four of 62 dialysis patients.
The diagnosis of ischaemic myocardial injury is HD+PD patients with IHD showed higher cTnT than difficult in the ESRD population. Several studies have HD+PD patients without IHD, and ET-1 concentrademonstrated that the older cardiac marker CK and tions were higher in HD patients with than without the more cardiac specific isoform CKMB are frequently IHD. In HD patients, there was a positive correlation elevated or indeterminate in ESRD patients without between cTnT and big ET-1. In HD patients with left other signs of acute ischaemic heart disease [4, 5] . ventricular hypertrophy (LVH ), serum cTnT, CKMB
The cardiac muscle isoforms of troponin T (cTnT ) mass and post-dialysis plasma big ET-1 were higher and troponin I (cTnI ) belonging to the myofibrillar than in patients with normal LVMI. Furthermore there troponin complex have been claimed to be superior markers of myocardial injury. Several studies have shown that the cardiac troponin T ELISA is a very creatinine were determined, in HD patients before the start marker in patients with acute myocardial ischaemia and at the end of a routine haemodialysis treatment.
[6 ]. In the first generation assay there was a slight Additionally, in the HD patients, plasma levels of ET-1 and cross-reactivity with skeletal muscle troponin T but big ET-1 were measured before and after dialysis. In HD the second generation cardiac troponin T ELISA shows patients 12-lead ECG and two-dimensional echocardiograno such cross-reactivity [7] .
phy were performed within 2 h after the end of the haemodiaHowever, increased serum concentrations of cTnT lysis. In 27 randomly selected HD patients left ventricular and, to a much lesser extent, of cTnI have been mass index (LVMI ) was determined using the Penn-cube reported in ESRD patients without any signs of acute formula (16). Left ventricular hypertrophy (LVH ) was myocardial ischaemia [8] . This problem has previously defined as LVMI >125 g/m2 [17] . The study protocol was approved by the local ethics committee and the subjects were been discussed by Haller et al. [9] . The mechanism of informed of the purpose of the study before giving their this troponin elevation is unclear. It is possible that voluntary consent.
cTnT is so sensitive that it detects subclinical myocardial cell injury or myocardial remodelling in the development of left ventricular hypertrophy whereas the cTnI Biochemical assays assays are less sensitive. On the other hand, the elevated serum concentrations of cTnT could also originate For analysis of serum from PD patients, peripheral venous from diseased skeletal muscle.
blood was collected in tubes without additives. In HD Endothelin-1 ( ET-1) is the most potent endogenous patients, blood samples were taken from the venous side of vasoconstrictor peptide known to date which is pro-the arteriovenous fistula. Tubes with EDTA were used for duced by conversion of the propeptide big ET-1. the preparation of plasma and tubes without additives for the preparation of serum. Specimens were centrifuged and Increased plasma levels of ET-1 and big ET-1 have and left ventricular hypertrophy/ischaemic heart disfor ET-1 (1-21), <0.03% for ET-2, <0.03% for ET-3 and ease in ESRD, we measured serum concentrations of 35% for big ET-1 fragment (22-38). The intra-assay variation cTnT, cTnI, CK and CKMB mass in chronic haemo-was 5.6% at a plasma concentration of 50 pmol/l [18]. For dialysis and peritoneal dialysis patients without acute determination of ET-1, rabbit ET-1 antiserum (E1), which cardiac symptoms. Additionally, in haemodialysis was diluted to give a specific binding of 35-40%, and 125I-patients, plasma levels of ET-1 and big ET-1 were labelled ET-1 (Amersham, UK ) were used. The detection determined and electrocardiography ( ECG) and echo-limit for the assay was 0.39 fmol per tube. The cross-reactivity for the E1 antiserum when the ET-1 (1-21) value is expressed cardiography was performed.
as 100% was: ET-1 (16-21), 16%; ET-2, 27%; ET-3, 8%; and The aim of the study was to investigate possible big ET-1, 0.45%. No cross-reactivity with big ET-1 (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) associations between concentrations of cTnT, other was observed at concentrations up to 1 mmol/l. The intracardiac markers, big ET-1, ET-1, and cardiac disease and inter-assay variations were 6 and 14%, respectively [18] . in dialysis patients.
Cardiac TnT was determined with the second generation troponin T ELISA (Enzymun-Test Troponin-T ) on ES 300 system (Boehringer Mannheim GmbH, Mannheim,
Subjects and methods
Germany). This assay uses the two cardiac-specific monoclonal antibodies M11.7 and M7 [7] . cTnI was measured with the Opus Troponin I assay (Behring Diagnostics,
Patients and protocol
Westwood, MA, USA) performed on the Opus analyser. CKMB mass was analysed by Microparticle Enzyme Sixty-two chronic dialysis patients (28 men, 34 women) without symptoms of acute myocardial ischaemia were Immunoassay (MEIA) technology with AxSYM system (Abbott Diagnostics, Abbott Park, IL, USA). A relative studied. Thirty-six patients (age; median 74, range 29-88 years) were treated with haemodialysis (HD) and 26 patients index (%CKMB) for CKMB mass defined as [CKMB mass (mg/l )/CK ( U/l )] ×100 was calculated. Serum CK and (age; median 58, range 32-80 years) with peritoneal dialysis (PD). Eighteen patients (13 HD, 5 PD) had chronic ischaemic creatinine were measured with dry chemistry using Ektachem 950ICR System (Johnson & Johnson Clinical Diagnostics, heart disease (IHD), which was defined as a history of angina pectoris and/or previous myocardial infarction. Fourteen Inc., Rochester, NY, USA). The total imprecisions (CV%) of the assays for cardiac markers were: 8.0% at 0.16 mg/l for patients (9 HD, 5 PD) had diabetes mellitus (DM ). Six patients (4 HD, 2 PD) had IHD and DM. In all patients, cTnT; 8.4% at 7.1 mg/l for cTnI; 8.3% at 3.8 mg/l for CKMB mass, and 8.6% at 192 U/l for the CK assay. serum concentrations of cTnT, cTnI, CKMB mass, CK and Values exceeding the upper reference limits were considered correlation was found between cTnT and CK, and elevated: cTnT Á0.10 mg/l, cTnI Á0.5 mg/l, CKMB mass cTnT and creatinine ( Table 1) .
Á5 mg/l, CK (males)Á174 U/l, and CK (females)Á144 U/l.
The discrimination limits for acute myocardial infarction HD patients (AMI ) were cTnTÁ0.20 mg/l, cTnIÁ0.5 mg/l, CKMB mass >15 mg/l and %CKMB >5%.
Serum concentrations of the cardiac markers, together with LVMI and plasma concentrations of ET-1 and big ET-1 are presented in In 27 patients LVMI was determined. In 18 of these percentiles for cTnI, cTnI, CKMB mass and %CKMB were 27 (72%) HD patients, left ventricular hypertrophy determined. If not otherwise stated, calculations for haemo-(LVMI >125 g/m2) was noted. In these patients serum dialysis patients were made by using data from pre-dialysis concentrations of cTnT and CKMB mass were signisamples. Statistical significance was defined as P<0.05. ficantly higher than in HD patients with normal LVMI ( Figure 2) . Eleven of 13 patients with serum Results cTnTÁ0.10 mg/l had left ventricular hypertrophy. All of five patients with heart valve disease had serum HD+PD patients cTnTÁ0.10 mg/l. In the 18 patients with LVH, 61% had elevated serum cTnT, whereas 22% of the 9 In HD+PD taken as one group (n=62), cTnT concen-patients without LVH had elevated cTnT concentratration wasÁ0.20 in 15 of 62 (24%) and Á0.50 mg/l tions. Plasma big ET-1 post-dialysis concentration was in 4 of 62 (6%) patients. None of the dialysis patients higher in patients with LVH than in patients without had CKMB mass >8 mg/l. The 97.5th percentiles LVH (P=0.01). (range) were: cTnT 0.54 mg/l (<0.02-1.6 mg/l ), cTnI
Moreover there was a significant correlation between 1.3 mg/l (<0.5-5.7 mg/l ), CKMB mass 8 mg/l (<1-8 LVMI and cTnT (r=0.40, P=0.04), LVMI and mg/l ) and %CKMB 28% (<1-44%).
CKMB mass (r=0.57, P=0.004), LVMI and Compared to dialysis patients without IHD (n=44), %CKMB (r=0.52, P=0.008) and between LVMI and dialysis patients with IHD (n=18) had higher serum big ET- ET-1 and other data are summarized in Table 1 . Serum In patients with DM without IHD (n=8), cTnT cTnT did not correlate with cTnI or CK. and CKMB mass were significantly higher (P=0.003 and P=0.001, respectively) than in patients without PD patients DM and IHD (n=36). Serum concentrations of cTnI and CK did not differ in dialysis patients with and The concentrations of the markers of myocardial without DM. damage are presented in Table 2 . The number of Male dialysis patients demonstrated higher serum patients with elevated cardiac markers are shown in concentrations of cTnT and CKMB mass than female Table 3 . Compared to PD patients without IHD (n= dialysis patients (P=0.05 and P=0.01, respectively). 21), PD patients with IHD (n=5) had higher serum In dialysis patients with ischaemic heart disease, there concentrations of cTnT (0.15 [0.08-0.46 ] vs <0.04 was no difference in serum cTnT between males (n= [<0.04-0.08]; P=0.01) and higher %CKMB (11 10) and females (n=8). Age and serum creatinine [6-11] vs 3 [2-7]; P=0.03). The other markers of showed no differences between gender. myocardial damage; cTnI, CKMB mass and CK, did Four patients (3 HD, 1 PD) had elevated cTnI not differ in PD patients with and without IHD. concentrations of 0.9, 1.1, 1.3, and 5.7 mg/l. The corresCorrelations between serum cTnT and other data ponding cTnT was 0.46, 0.12, 0.14 and 0.10 mg/l, are summarized in Table 1 . respectively. CKMB mass was <5 mg/l in these patients. Two of them had IHD (cTnI 1.1 and 0.9 mg/l ) Discussion and one had DM (cTnI 1.3 mg/l ).
A positive correlation was found between serum concentrations of cTnT and the following variables: The main findings in the present study were that, there was an association between serum cTnT and LVH and CKMB mass, %CKMB and age, whereas a negative Fig. 1 . A. Serum concentrations of cTnT in haemodialysis+peritoneal dialysis (HD+PD) patients without ischaemic heart disease (n=44) and in HD+PD patients with ischaemic heart disease (n=18). B. Plasma ET-1 concentrations in haemodialysis patients without ischaemic heart disease (n=23) and in haemodialysis patients with ischaemic heart disease (n=13). No IHD: without ischaemic heart disease. IHD: with ischaemic heart disease. Column: median. Whisker: interquartile range. between serum cTnT and IHD in dialysis patients adequate exercise tests due to limited exercise tolerance. Symptoms may be masked by underlying diseases, and without acute myocardial infarction. Furthermore HD patients with IHD had higher plasma ET-1 than peripheral neuropathies may alter the perception of chest pain. Therefore the use of reliable biochemical patients without IHD and there was a correlation between serum cTnT and plasma big ET-1 in HD markers for the detection of myocardial damage is essential in these patients. Since serum baseline levels patients.
The diagnosis of myocardial ischaemia is difficult in of CKMB can be elevated in ESRD without clinical signs of myocardial ischaemia [19] , more specific ESRD patients since they often demonstrate abnormal baseline ECGs and often are not able to perform markers are in great demand. Two proteins of the troponin complex, TnT and second generation ELISA in 20 of 36 (56%) HD patients are consistent with other recent findings of a high frequency of increased serum cTnT in ESRD the membranes of injured myocytes may lose their patients without symptoms of acute myocardial isch-integrity and allow the exposure of intracellular proaemia [22] . Furthermore we showed that also PD teins to the extracellular environment. This has been patients have a high percentage (31%) of elevated discussed by Missov et al. who found increased serum serum cTnT. troponin I in patients with severe congestive heart The reasons for the cTnT elevations in renal disease failure when using an assay with very high analytical are still unclear. Like Frankel et al. [23] we found no sensitivity [27] . It has also been shown experimentally difference between cTnT before and after haemodia-that cTnT concentration increases in rat left ventricular lysis. This eliminates the possibility that a cross-after trophic stimuli and pressure overload [28] . reacting dialysable substance caused the cTnT eleva-Furthermore Haller et al. reported a high prevalence tion. In accordance with several previous reports, we of concentric left ventricular hypertrophy in a haemodid not find any positive correlation between serum dialysis population with increased cTnT levels [9] . cTnT and serum creatinine. On the contrary we found Thus cTnT may be an early marker of cardiac a negative correlation between these two analytes. This hypertrophy. could be explained by a lower muscle mass in the older Another novel finding was the positive correlation and severely ill patients in our study population. This between plasma big ET-1 and serum cTnT. Although was indicated by a significant negative correlation it does not prove causal relationship, it might between age and creatinine (data not shown).
strengthen the hypothesis that endothelin is associated Extracardiac expression of cTnT in ESRD patients with cardiac disease in dialysis patients. is controversial. McLaurin et al. reported evidence of
In the present study, there was a correlation between cTnT expression in skeletal muscle of dialysis patients big ET-1 levels post-dialysis and LVMI in HD patients, [24] . However, they did not use the same antibodies and HD patients with a history of IHD showed higher (M11.7 and M7) that are used in the second generation ET-1 concentrations than HD patients without IHD. cTnT ELISA. On the contrary, Haller et al., using The latter finding is in accordance with a recent study reverse transcription-PCR and immunoblot, immuno investigating 53 HD patients which showed that fluorescence methods, found no evidence of cTnT haemodialysis patients with IHD had higher plasma expression in skeletal muscle biopsies of ESRD patients concentrations of ET-1 and big ET-1 than haemodia- [25] . Furthermore Ricciuti et al. showed that cardiac lysis patients without IHD [29] . The elevated plasma TnT isoforms expressed in renal diseased skeletal concentrations of ET-1, which were noted in ischaemic muscle will not cause false-positive results by the heart disease, may be due to episodes of ischaemia second generation cTnT assay [26 ] . Therefore it is which is known to stimulate ET synthesis [30] . On the most likely that serum cTnT in ESRD patients, as other hand, ET-1 may cause myocardial ischaemia measured by the assay used in our study, originates since Pernow et al. demonstrated that exogenous ET-1 from the heart. elicited coronary vasoconstriction in healthy humans In the present study we showed an association [12] . In addition, ET-1 has been associated with the between serum cTnT and cardiac disease in dialysis development of left ventricular hypertrophy [31] and patients without clinical or electrocardiographic signs Demuth et al. have demonstrated a significant positive of acute myocardial infarction. One explanation for correlation between elevated plasma ET concentration this could be a high sensitivity of cTnT to detect and an increased LV mass in ESRD patients [32] . subclinical myocardial injury and/or remodelling of a Left ventricular hypertrophy may be a reflection of hypertrophic left ventricle in dialysis patients. In the arterial hypertension and blood pressure per se might present study 72% of the HD patients had left ventricuinfluence ET-1 and big ET-1. However, in the present lar hypertrophy, which may cause an increased suscepstudy mean arterial blood pressure in HD patients tibility of the myocardium to ischaemia. These patients post-dialysis did not correlate with plasma ET-1, big had higher serum cTnT and CKMB mass than the ET-1, serum cTnT or with CKMB mass. The correlapatients with normal left ventricular dimensions. We tion between blood pressure and LVMI showed a trend also found a correlation between cTnT and LVMI in (P=0.07) (data not shown). HD patients. To our knowledge this has not been Our findings of higher serum cTnT concentrations shown before. Furthermore, in HD+PD patients within diabetic dialysis patients without IHD than in out clinical evidence of acute myocardial ischaemia, patients without diabetes mellitus and IHD, are conthose with a history of ischaemic heart disease showed sistent with Ooi et al., who reported a high percentage higher serum cTnT than patients without IHD. The (58%) of increased cTnT in haemodialysed patients latter finding is in accordance with Haller et al. who with diabetes mellitus [33] . The authors speculate that reported a correlation between the plasma cTnT conadvanced glycosylation end-products could induce centration and indicators of coronary artery disease in cTnT expression in noncardiac cells and affect mem-ESRD patients [25] . brane integrity. However, diabetic patients are at high In hypertrophy more ultrastructural components are risk of developing ischaemic heart disease, which may synthesized with increased synthesis of enzymes and be present but undiagnosed in these patients. We found increased number and size of the cardiac muscle fibres.
that not only serum cTnT but also serum CKMB mass This may lead to an increased leakage of cTnT and other structural proteins from the cells. Furthermore was higher in patients with diabetes.
